Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Artivion (AORT) Research & Development (2016 - 2025)

Artivion's Research & Development history spans 16 years, with the latest figure at $9.1 million for Q4 2025.

  • For Q4 2025, Research & Development rose 23.2% year-over-year to $9.1 million; the TTM value through Dec 2025 reached $31.0 million, up 8.92%, while the annual FY2025 figure was $31.0 million, 8.92% up from the prior year.
  • Research & Development reached $9.1 million in Q4 2025 per AORT's latest filing, up from $8.1 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $11.8 million in Q3 2022 to a low of $6.4 million in Q3 2023.
  • Average Research & Development over 5 years is $8.1 million, with a median of $7.7 million recorded in 2021.
  • Peak YoY movement for Research & Development: soared 73.28% in 2021, then plummeted 45.58% in 2023.
  • A 5-year view of Research & Development shows it stood at $9.5 million in 2021, then decreased by 12.22% to $8.3 million in 2022, then dropped by 7.94% to $7.6 million in 2023, then decreased by 3.15% to $7.4 million in 2024, then rose by 23.2% to $9.1 million in 2025.
  • Per Business Quant, the three most recent readings for AORT's Research & Development are $9.1 million (Q4 2025), $8.1 million (Q3 2025), and $7.1 million (Q2 2025).